Discover 3,602 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,602
Active & Responsive
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
for
Volume Loss (Soft Tissue Ptosis or Atrophy )
Location: Pasadena CA
Sponsor: Kalpna Kay Durairaj, MD, FACS
Sex: All
Age: 21 - 65
Code: NCT07419854
Recruiting
Active & Responsive
Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
for
Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Location: Pasadena CA
Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation
Sex: Female
Age: 35 - 55
Code: NCT07810504
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Los Angeles CA, Long Beach CA, Pomona CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for
Venous Leg Ulcer (VLU)
Location: Los Angeles CA, Vista CA, Fresno CA, San Francisco CA,
Sponsor: MediWound Ltd
Sex: All
Age: 18+
Code: NCT06568627
Phase 3, Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Los Angeles CA, Montebello CA, Lakewood CO, Bellevue WA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: South Pasadena CA, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase 2, Recruiting
Active & Responsive
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: South Pasadena CA, Arcadia CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT07741968
Recruiting
Active & Responsive
ACP-204 in Adults With Alzheimer's Disease Psychosis
for
Alzheimer's Disease Psychosis
Location: Pasadena CA, Costa Mesa CA, Fresno CA, Scottsdale AZ,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT06159673
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for
Graves' Disease, Graves Disease
Location: Pasadena CA, Orange CA, Carlsbad CA, San Jose CA,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07570316
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Los Angeles CA, Pasadena CA, Tarzana CA, Long Beach CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Los Angeles CA, Pasadena CA, Long Beach CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Location: Los Angeles CA, Irvine CA, Stanford CA, Wichita KS,
Sponsor: Valencia Technologies Corporation
Sex: All
Age: 18+
Code: NCT05685433
Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Los Angeles CA, Long Beach CA, Anaheim CA, Irvine CA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase 3, Recruiting
Active & ResponsiveNew
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus
Location: Los Angeles CA, Albuquerque NM, Dallas TX, Paris TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07662109
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Los Angeles CA, Rancho Mirage CA, Fresno CA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Los Angeles CA, Duarte CA, Long Beach CA,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Location: Los Angeles CA, Beverly Hills CA, Palo Alto CA,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase 1, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Los Angeles CA, Fullerton CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Los Angeles CA, Santa Monica CA, Orange CA, Irvine CA,